Ireland· IE-PA-PA2299/024/001
Uromitexan 100mg/ml Solution for Injection or Infusion
A mesna product containing mesna, registered in Ireland by Baxter Holding B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Mesna is registered in 12 of 19 countries.
Countries holding a registration under ATC V03AF01 (mesna), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Mesna · ATC V03AF01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Mesna
- Manufacturer
- Baxter Holding B.V.
- Country
- Ireland (IE)
- ATC code
- V03AF01
- ATC class
- Mesna
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2299/024/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mesna in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesmesnaHikma Pharmaceuticals USA Inc.
- CzechiaUROMITEXANBaxter Oncology GmbH, Halle
- SpainMESNA ALTAN 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFGAltan Pharmaceuticals Sa
- FinlandUromitexan Cum ConservansBaxter Oy
- United KingdomMesna 1g/10ml solution for injection ampoulesA A H Pharmaceuticals Ltd
- SwedenUromitexan (med konserveringsmedel) 100 mg/ml Injektionsvätska, lösningBaxter Medical AB
- FranceMESNA EG 100 mg/ml, solution injectable pour perfusionEG LABO - LABORATOIRES EUROGENERICS
- NetherlandsUromitexan, omhulde tablet, 400 mgBaxter B.V.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Uromitexan
- Belgium · Uromitexan
- Bulgaria · Уромитексан
- Czechia · Uromitexan
- Germany · Mesna Cell, Mesna-Cell Stadapharm
- Denmark · Uromitexan, Uromitexan Cum Conservans
- Estonia · Uromitexan
- Spain · Mesna Altan, Mucofluid
- Finland · Uromitexan, Uromitexan Cum Conservans
- France · Mesna Eg, Uromitexan
- United Kingdom (Northern Ireland) · Mesna Baxter Healthcare
- Greece · Uromitexan
- Croatia · Uromitexan
- Hungary · Uromitexan
- Iceland · Uromitexan
- Italy · Uromitexan
- Lithuania · Uromitexan
- Luxembourg · Uromitexan
- Latvia · Uromitexan
- Malta · Uromitexan
- Netherlands · Uromitexan
- Norway · Uromitexan
- Poland · Uromitexan
- Portugal · Uromitexan
- Romania · Uromitexan
- Sweden · Uromitexan, Uromitexan (Med Konserveringsmedel)
- Slovakia · Uromitexan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5c486cf9-9a1d-41b7-ad11-c882157f6043 GET /v1/drugs/5c486cf9-9a1d-41b7-ad11-c882157f6043?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection/infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V03AF",
"V03AF01"
],
"strength": null,
"pa_number": "PA2299/024/001",
"substances": [
"Mesna"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "25/09/1996",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about mesna.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.